Blood-Biomarkers and Risk Factors of Acute Brain Injury associated with Neurodisability in Ugandan Children [BRAIN-Child]
乌干达儿童神经功能障碍相关的急性脑损伤的血液生物标志物和危险因素 [BRAIN-Child]
基本信息
- 批准号:10682592
- 负责人:
- 金额:$ 17.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Brain InjuriesAddressAdultAfricanAgeAstrocytesAttentionBiological MarkersBloodBrain Hypoxia-IschemiaBrain InjuriesCerebral MalariaChildChildhoodChildhood InjuryCognitionCognitiveCollaborationsCommunitiesComplicationConsultCountryDataDiseaseEducational workshopFosteringFunctional disorderFutureGlial Fibrillary Acidic ProteinGlucoseGoalsHuman ResourcesImpaired cognitionIncomeInfrastructureInjuryInterdisciplinary StudyKnowledgeMalariaMemoryMethodsNeurocognitive DeficitNeuronal InjuryNeuronsNeuropsychologyOutcomePatient-Focused OutcomesProteinsResearchResearch DesignResourcesRiskRisk FactorsRoleShort-Term MemorySiteStudentsSupervisionSurvivorsTechnologyTherapeutic InterventionTrainingTraining SupportTraumatic Brain InjuryUCHL1 geneUgandaUniversitiesWorkYouthbiomarker identificationbrain parenchymaburden of illnesscell injurycerebral microvasculaturecognitive functiondisabilityendothelial dysfunctionfollow-upglobal healthlow and middle-income countriesmalaria infectionmembermild traumatic brain injurymortalitynervous system disordernew therapeutic targetpediatric traumatic brain injurypreventprognostic toolrisk mitigationrisk predictionscreeningsymposiumtau Proteinsvirtual
项目摘要
ABSTRACT
Neurocognitive impairment (NCI) is a common complication of acute brain injury in two unrelated nervous system
disorders: cerebral malaria (CM) and traumatic brain injury (TBI). In children ages 5–15 years, six of the top 15
causes of mortality and disability are injury-related, and 95% of these occur in low- and middle- income countries
(LMICs). The burden of TBI in LMICs is not fully known but is estimated at three times more than in high-income
countries. Meanwhile, the high burden of pediatric CM is borne almost exclusively by African nations. Thus, there
is a global need for reliable, noninvasive prognostic tools that can predict the risk of future NCI as early as
possible after acute brain injury. Biomarkers of brain injury—proteins expressed in the brain parenchyma (by
neurons and astrocytes)—can be useful prognostic tools in brain injury. Neuronal injury markers tau and UCH-
L1, and astrocyte injury marker GFAP can predict NCI after moderate/severe TBI; likewise, tau and UCH-L1 are
elevated in CM and predict future NCI. Further, the pathophysiologies of CM and TBI have overlapping features:
injury to the brain’s microvasculature leads to hypoxia/ischemia with glucose abnormalities, cellular injury, and
endothelial dysfunction. These effects interact to complicate acute brain injury resulting in impaired cognitive
functions. Our group has led studies identifying biomarkers and risk factors of pediatric CM in an LMIC setting,
but no such research has been conducted for pediatric TBI to understand brain injury in children at risk of NCI
after TBI. To address this gap in knowledge, we propose a study to: (1) screen a specific set of blood biomarkers
implicated in NCI after CM for their roles in NCI after TBI in Uganda and (2) build on the successful work on CM
and NCI by members of our research team within Global Health Uganda and Makerere University, expanding
infrastructure and personnel to conduct research on NCI after TBI. We hypothesize that blood biomarkers of
acute brain injury and risk factors including glucose abnormalities, cellular injury, and endothelial dysfunction
may help identify children at risk of NCI after acute TBI. Our research and collaboration aims are as follows:
Research aim 1 will determine if biomarkers and risk factors of brain injury elevated in pediatric CM are elevated
in pediatric TBI. We will determine if children with moderate/severe TBI (N=80) have elevated biomarkers
compared to mild TBI (N=120) or controls (N=100) and if the biomarkers are associated with known risk factors
of brain injury. Aim 2 will determine if elevated brain injury biomarkers in pediatric TBI correlate with NCI at 6-
month follow-up, to be assessed using: (1) K-ABC for overall cognition and working memory, (2) TOVA for
attention, and (3) BNIS-C for cognitive function screening. Our capacity building aim will expand capacity for
interdisciplinary NCI research in Uganda by supporting training in neuropsychological methods that apply to NCI
after pediatric TBI. This study will fill a key gap in knowledge regarding biomarkers and risk factors of acute brain
injury associated with NCI after pediatric TBI in a malaria-endemic setting, while simultaneously building global
collaborations and capacity for sustained neuropsychological research in diverse nervous system disorders.
抽象的
神经认知障碍(NCI)是两个无关神经系统中急性脑损伤的常见并发症
疾病:脑疟疾(CM)和创伤性脑损伤(TBI)。在5-15岁的儿童中,前15名中有6个
死亡率和残疾的原因是与伤害有关的,其中95%在低收入国家和中等收入国家中发生
(LMIC)。 LMIC中TBI的Burnen尚不完全清楚,但估计是高收入的三倍
国家。同时,小儿广告的高燃烧几乎完全由非洲国家诞生。那,那里
全球需要可靠的无创预后工具,可以预测未来NCI的风险
急性脑损伤后可能。脑损伤的生物标志物 - 在脑实质中表达的蛋白质(通过
神经元和星形胶质细胞) - 在脑损伤中可能是有用的预后工具。神经元损伤标记tau和Uch-
L1和星形胶质细胞损伤标记GFAP可以预测中度/重度TBI后NCI;同样,tau和uch-l1是
CM升高并预测未来的NCI。此外,CM和TBI的病理生理具有重叠的特征:
大脑微举行的损伤导致缺氧/缺血异常,葡萄糖异常,细胞损伤和
内皮功能障碍。这些影响与复杂的急性脑损伤相互作用,导致认知受损
功能。我们的小组领导的研究确定了在LMIC环境中的小儿CM的生物标志物和危险因素,
但是,尚未针对小儿TBI进行此类研究,以了解NCI风险的儿童的脑损伤
在TBI之后。为了解决知识的这一差距,我们提出了一项研究:(1)筛选一组特定的血液生物标志物
CM之后在NCI实施,因为其在乌干达TBI之后在NCI中的角色和(2)在CM上成功的工作建立
我们的NCI由我们的全球健康乌干达和马克雷尔大学的研究团队成员扩展
在TBI之后,基础设施和人员对NCI进行研究。我们假设该血液生物标志物的
急性脑损伤和危险因素,包括葡萄糖异常,细胞损伤和内皮功能障碍
急性TBI后可能有助于识别有NCI风险的儿童。我们的研究和协作目的如下:
研究目标1将确定小儿CM升高的生物标志物和脑损伤的危险因素是否升高
在小儿TBI中。我们将确定中度/重度TBI(n = 80)的儿童是否具有升高的生物标志物
与轻度TBI(n = 120)或对照(n = 100)相比,如果生物标志物与已知危险因素相关
脑损伤。 AIM 2将确定小儿TBI中脑损伤生物标志物的升高是否与6--的NCI相关
每月随访,将使用:(1)K-ABC进行整体认知和工作记忆,(2)TOVA
注意,(3)BNIS-C进行认知功能筛选。我们的能力建设目标将扩大能力
通过支持适用于NCI的神经心理学方法的培训,乌干达的NCI跨学科研究
小儿TBI之后。这项研究将填补有关生物标志物和急性大脑危险因素知识的关键空白
小儿TBI后与NCI相关的伤害在疟疾末端环境中,同时建立全球
在多种神经系统疾病中持续的神经心理学研究的合作和能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul Bangirana其他文献
Paul Bangirana的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul Bangirana', 18)}}的其他基金
Blood-Biomarkers and Risk Factors of Acute Brain Injury associated with Neurodisability in Ugandan Children [BRAIN-Child]
乌干达儿童神经功能障碍相关的急性脑损伤的血液生物标志物和危险因素 [BRAIN-Child]
- 批准号:
10538862 - 财政年份:2022
- 资助金额:
$ 17.48万 - 项目类别:
Malarial Impact on Neurobehavioral Development (MIND)
疟疾对神经行为发育(MIND)的影响
- 批准号:
10405271 - 财政年份:2008
- 资助金额:
$ 17.48万 - 项目类别:
Malarial Impact on Neurobehavioral Development (MIND)
疟疾对神经行为发育(MIND)的影响
- 批准号:
10083231 - 财政年份:2008
- 资助金额:
$ 17.48万 - 项目类别:
Malarial Impact on Neurobehavioral Development (MIND)
疟疾对神经行为发育(MIND)的影响
- 批准号:
10675323 - 财政年份:2008
- 资助金额:
$ 17.48万 - 项目类别:
Malarial Impact on Neurobehavioral Development (MIND)
疟疾对神经行为发育(MIND)的影响
- 批准号:
10548882 - 财政年份:2008
- 资助金额:
$ 17.48万 - 项目类别:
相似国自然基金
通过调控颈淋巴结引流促进急性颅脑损伤后神经修复与再生——基于脑-颈淋巴结通路概念的功能与机制研究
- 批准号:82311530117
- 批准年份:2023
- 资助金额:39 万元
- 项目类别:国际(地区)合作与交流项目
应用人工智能深度学习技术构建轻中度颅脑损伤急性期颅内血肿进展预判体系的研究
- 批准号:82171381
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
Netrin-1抑制急性缺血性脑损伤中小胶质细胞介导的炎症反应的作用及机制
- 批准号:82171286
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
基于小胶质细胞HMGB1/TLR4/NF-κB信号通路探讨针刺在急性一氧化碳中毒脑损伤中的抗炎机制
- 批准号:
- 批准年份:2020
- 资助金额:34 万元
- 项目类别:地区科学基金项目
己糖激酶2通过蛋白激酶活性调节星形胶质细胞外泌体生成参与急性缺血性脑损伤
- 批准号:82071321
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for AcuteHeadache in Aneurysmal Subarachnold Hemorrhage
翼腭窝 (PPF) 阻滞作为阿片类药物节省治疗动脉瘤性蛛网膜下腔出血的急性头痛
- 批准号:
10584712 - 财政年份:2023
- 资助金额:
$ 17.48万 - 项目类别:
LRP1 as a novel regulator of CXCR4 in adult neural stem cells and post-stroke response
LRP1 作为成体神经干细胞和中风后反应中 CXCR4 的新型调节剂
- 批准号:
10701231 - 财政年份:2023
- 资助金额:
$ 17.48万 - 项目类别:
Microglial process convergence following brain injury
脑损伤后小胶质细胞过程收敛
- 批准号:
10657968 - 财政年份:2023
- 资助金额:
$ 17.48万 - 项目类别:
Identifying and modeling immune correlates of protection against congenital CMV transmission after primary maternal infection
原发性母体感染后预防先天性巨细胞病毒传播的免疫相关性的识别和建模
- 批准号:
10677439 - 财政年份:2023
- 资助金额:
$ 17.48万 - 项目类别:
Feasibility of Using PET Imaging for Detection of Treatment-Induced Changes in Chronic Neuroinflammation Following TBI
使用 PET 成像检测 TBI 后治疗引起的慢性神经炎症变化的可行性
- 批准号:
10703823 - 财政年份:2023
- 资助金额:
$ 17.48万 - 项目类别: